PD-L1 Non-Lung (Nivolumab) IHC | Casandra.ai

|Login List a Test

Loading...

Cloud-based ordering platform and AI onramp for diagnostic labs.

Where providers find sponsored, no-cost lab tests.

FDA-approved companion diagnostics for precision medicine therapies.

For Providers

Overview
EHR Ordering
Lab Stewardship
Integration

For Labs

Overview
Test Catalog
Admin + Routing
EHR Ordering
LIS/LIMS Overlay
AI + Analytics
Security + Compliance
Pricing

About Casandra

Overview
Leadership
Contact
Newsroom
Casandra vs Epic Aura

Get Started

Get a Demo

Made with ❤️ in the 🇺🇸

© 2026 Casandra.ai. All rights reserved.

PD-L1 Non-Lung (Nivolumab) IHC | Casandra.ai

Casandra

Casandra Test Code QD01508Version 1 (DRAFT)

Performing Lab

Lab Quest DiagnosticsLab Test ID 93793

PD-L1 Non-Lung (Nivolumab) IHC

Also known as: PDL1, 28-8 (Dako), PDL-1

Clinical Use

Use

Not provided.

Special Instructions

Not provided.

Limitations

Not provided.

Test Details

Methodology

Immunoassay (IHC)

Biomarkers

PD-L1

Protein

IHC

Expression • Ordinal Score (e.g., TPS, CPS, H-score)

Result Turnaround Time

Not provided.

Related Documents

For more information, please review the documents below

Lab test overview

Specimen Requirements

Not provided.

Similar Tests

Other tests from different labs that may be relevant

PD-L1, IHC (Nivolumab)

PD-L1 by IHC, Opdivo®

PD-L1 IHC (Nivolumab) Urothelial Carcinoma

PD-L1 28-8 pharmDx by Immunohistochemistry with Interpretation, nivolumab (OPDIVO)

ARUP Laboratories

PD-L1 IHC (Nivolumab) Squamous Cell Carcinoma of the Head and Neck

PD-L1, IHC (Atezolizumab), Non-Small-cell Lung Cancer

PD-L1 IHC, NSCLC Keytruda®

PD-L1 by IHC, 22C3, Keytruda®

PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC